Clinical Trials Logo

Unrecognized Condition clinical trials

View clinical trials related to Unrecognized Condition.

Filter by:

NCT ID: NCT06464328 Completed - Clinical trials for Unrecognized Condition

The Impact of Tai Chi Combined With Music Therapy Intervention on Depression and Anxiety Among College Students

Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of Tai Chi combined with music therapy on alleviating depression and anxiety among college students. Depression and anxiety are prevalent among college students and have a significant impact on their lives and academic performance. Therefore, exploring effective interventions is crucial for promoting the mental health of college students.

NCT ID: NCT06339996 Recruiting - Clinical trials for Unrecognized Condition

Male Supplements for Sperm Quality and Aging

Start date: March 26, 2024
Phase: N/A
Study type: Interventional

This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.

NCT ID: NCT06243146 Recruiting - Clinical trials for Unrecognized Condition

Titration of Inspired Oxygen to Decrease the Incidence of Postoperative Pulmonary Complications

Start date: June 20, 2024
Phase: N/A
Study type: Interventional

Lung cancer is with the highest incidence rate and mortality among people over 60 years old in China. Postoperative pulmonary complications (PPCs) is the most common complication after pneumonectomy, which has a significant impact on the short-term and long-term prognosis of patients, and is even the primary risk factor leading to early postoperative death. High fraction of inspired oxygen (FiO2) is an independent risk factor for PPCs, but it is difficult to achieve oxygenation while avoiding hyperxemia during one lung ventilation (OLV). We will randomly divide patients who plan to undergo thoracoscopic pulmonary resection into two groups. During OLV, titration will be used to determine the optimal FiO2 for titration group while FiO2 of 80% will be used for mechanical ventilation for control group. The incidence of postoperative PPCs, hypoxia/hyperxemia, oxygenation index (PaO2/FiO2) and intrapulmonary shunt rate (Qs/Qt), oxidative stress indicators, and prolonged hospital stay will be observed in both groups of patients. We will evaluate the effectiveness and safety of titrating inhaled oxygen concentration in lung protection during OLV.

NCT ID: NCT05929053 Not yet recruiting - Clinical trials for Unrecognized Condition

Impact of Vaccine Education Program on Vaccine Advocacy and Vaccine Literacy

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This research will be carried out as a randomized controlled study with a waitlist in parallel design to evaluate the effect of the vaccine education and vaccine advocacy program prepared according to The Integrated Change Model on the level of vaccination literacy and the transformation into vaccine advocates. Research hypothesis "H0a: Vaccine education program prepared according to The Integrated Change Model does not affect vaccine literacy, H0b: The vaccine training program prepared according to the integrated change model does not affect the concepts (information sources, intention, attitude, behavior, obstacles) in the integrated change model determined for vaccine advocacy. At the end of the training, it is thought that the mothers in the experimental group will be different from the control group regarding vaccine literacy and the vaccine advocacy concepts (information sources, intention, attitude, behavior) in the model.

NCT ID: NCT05908604 Completed - Clinical trials for Unrecognized Condition

Use of a Robot in Medication Management for Older People's Home Care

Start date: August 30, 2021
Phase: N/A
Study type: Interventional

Non-randomized controlled clinical trial was used. Data were collected using the Working Time Tracking Form in three data collection points (baseline, at 1 month and at 2 month). The participants were home care professionals who carried out home care clients' medication management. Home care clients were allocated into intervention and control groups (n=64 and 46, respectively) based on whether or not they used the robot. The statistical analysis methods were used.

NCT ID: NCT05873075 Recruiting - Clinical trials for Unrecognized Condition

Intravascular Laser Irradiation of Blood Use in Poor Ovarian Responders

Start date: April 27, 2023
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the effects of intravascular laser irradiation of blood on outcomes of in vitro fertilization cycles in poor ovarian responders.

NCT ID: NCT05795998 Completed - Clinical trials for Unrecognized Condition

Turkish Adaptation of Romantic Relationship Sabotage Scale Validity and Reliability Study

T-RSS
Start date: January 15, 2022
Phase:
Study type: Observational [Patient Registry]

In this cross-sectional and relationship-seeking study, it was aimed to adapt the Romantic Relationship Sabotage Scale (T-RSS), developed by Racquel Peel, into Turkish, for the reasons why partners sabotage the relationship in romantic relationships.

NCT ID: NCT05478616 Recruiting - Clinical trials for Unrecognized Condition

Expression of Endometrium During Window of Implantation

Start date: July 1, 2022
Phase:
Study type: Observational

The aim of this study was to investigate the expression of endometrium during window of implantation between natural cycles and artificial cycles.

NCT ID: NCT05358002 Completed - Clinical trials for Unrecognized Condition

Comparative Study Between Frontalis Flap Advancement Versus Frontalis Sling Operations in Mangment of Congenital Blepharoptosis

Start date: May 20, 2020
Phase: N/A
Study type: Interventional

A prospective comparative study between the results obtained by applying frontalis muscle flap advancement and frontalis sling operations for correction of congenital ptosis with poor levator muscle function. Study will include evaluation of the functional and cosmetic results, recurrence rates, and the incidence and varieties of different complications between the two techniques

NCT ID: NCT05319132 Recruiting - Clinical trials for Unrecognized Condition

Evaluate DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell From Subjects With ROSAH Syndrome

ROSAH
Start date: September 6, 2022
Phase:
Study type: Observational

Alpha-1 kinase (ALPK1) has been reported as a potential causative gene for ROSAH Syndrome. Genetic variants including T237M have been found in ROSAH Syndrome patients. Our in-house study has found that T237M mutation leads to hyperactivity of ALPK1, which may be the cause of the inflammatory syndromes found in ROSAH Syndrome patients. We hypothesize that T237M mutation ALPK1 cause ROSAH Syndrome and an ALPK1 inhibitor can be a potential therapy for treating this disease. To test our hypothesis, we designed an experiment in which ex vivo peripheral blood mononuclear cells (PBMCs) from ROSAH Syndrome patients will be exposed to a potent ALPK1 inhibitor (DF-003) or placebo. We expect to see downregulation of activated inflammatory genes, chemokine/cytokines and acute phase proteins in the ROSAH Syndrome patient samples that are exposed DF-003.